Cart
Shopping cart

Margaret Richters

Zinzino Independent Partner

¡Bienvenido! Soy su consultor independiente, aquí para guiarlo en su viaje de salud.

Press releases - lunes, 5 de febrero de 2024 15:00 CET

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024

Zinzino group revenue increased with a total of 15%, compared with the previous year.

The revenue in January for Zinzino's sales markets increased by 17% and amounted to SEK 140.2 (120.3) million. Faun Pharma's external sales decreased by 11% and amounted to SEK 8.1 (9.1) million. Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year.

Revenues were distributed as follows:

Regions, mSEK 24-Jan 23-Jan Change
The Nordics 22.6 23.4 -3%
Central Europe 41,0 28.5 44%
East Europe 31.8 32.8 -3%
South & West Europe 21.8 15.9 37%
The Baltics 8,0 7.4 8%
North America 10.1 6.3 60%
Asia-Pacific 3.9 4.6 -15%
Africa 1,0 1.4 -29%
Zinzino 140.2 120.3 17%
Faun Pharma 8.1 9.1 -11%
Zinzino Group 148.3 129.4 15%

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ)